Neratinib in patients with HER2-mutant, metastatic cervical...

Gynecologic Oncology 2019 / 06 Vol. 154

Neratinib in patients with HER2-mutant, metastatic cervical cancer: findings from the phase 2 SUMMIT ‘basket’ trial

D’Souza, A., Roman, L.D., Saura, C., Braña, I., Shapiro, G.I., Passalacqua, R., Piha-Paul, S., Cutler, R.E., Shahin, S., Eli, L.D., Xu, F., Dujka, M., Lalani, A.S., Bryce, R., Meric-Bernstam, F., Soli
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
154
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.04.033
Date:
June, 2019
File:
PDF, 63 KB
english, 2019
Conversion to is in progress
Conversion to is failed